T-cell activation involves two phases, enabling a more precise immune response. This insight may boost cancer immunotherapy effectiveness. A research team led by Wolfgang Kastenmüller and Georg ...

During a live event, Xiuning Le, MD, PhD, discussed updated intracranial efficacy, overall survival, and safety of ...

Five scientists from The University of Texas MD Anderson Cancer Center will be recognized with Scientific Achievement Awards ...

A team of researchers from the University of Chicago, in collaboration with researchers from the University of Pittsburgh, ...

In some patients with advanced triple-negative breast cancer, Trodelvy plus Keytruda was associated with an improvement in disease progression.

The UT Health RGV Cancer and Surgery Center is set to open Aug. 4 after experiencing multiple construction delays Oncology ...

Researchers from Tokyo Metropolitan University have found that the motion of unlabeled cells can be used to tell whether they ...

Gilead Sciences said on Monday a late-stage study showed that its drug Trodelvy used in combination with Merck's ...

A protein that stops cells from dividing in response to damage or stress could be a new biomarker or therapeutic target for ...

Cell crowding causes high-grade breast cancer cells to become more invasive by activating a molecular switch that causes the cells to shrink and spread.

After more than five decades of mystery, scientists have finally unveiled the detailed structure and function of a ...